The relationship between high density lipoprotein subclass profile and apolipoprotein concentrations

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Endocrinological Investigation

• Publication date

  2011-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF03346714PMID 21747218
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The relationship between high density lipoprotein subclass profile and plasma lipids concentrations

  2010cited by this paper
• Proteomics of Apolipoproteins and Associated Proteins From Plasma High-Density Lipoproteins

  2010cited by this paper
• Macrophage cholesterol efflux correlates with lipoprotein subclass distribution and risk of obstructive coronary artery disease in patients undergoing coronary angiography

  2009cited by this paper
• Relationship between apolipoprotein C-III concentrations and high-density lipoprotein subclass distribution.

  2009cited by this paper
• Influence of apolipoproteinCII concentrations on HDL subclass distribution.

  2009cited by this paper
• The influence of plasma apolipoprotein A‐II concentrations on HDL subclass distribution

  2008cited by this paper
• Relationship between plasma apolipoproteinB concentrations, apolipoproteinB/apolipoproeinA-I and HDL subclasses distribution.

  2008cited by this paper
• High-Density Lipoprotein Reduces the Human Monocyte Inflammatory Response

  2008cited by this paper
• Erratum to “Relationship between plasma apolipoproteinB concentrations, apolipoproteinB/apolipoproteinA-I and HDL subclasses distribution” [Clinica Chimica Acta 388 (2008) 148–155]

  2008cited by this paper
• An apolipoprotein A-I mimetic dose-dependently increases the formation of prebeta1 HDL in human plasma.

  2008cited by this paper
• Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis

  2008cited by this paper
• HDL particle as a risk factor for cardiovascular diseases in healthy people

  2008cited by this paper
• Apolipoprotein A-II is catabolized in the kidney as a function of its plasma concentration Published, JLR Papers in Press, July 24, 2007.

  2007cited by this paper
• Relationship Between Apolipoprotein Concentrations and HDL Subclasses Distribution

  2007cited by this paper
• Relationship between apolipoproteins and the alteration of HDL subclasses in hyperlipidemic subjects.

  2007cited by this paper
• Alterations of high-density lipoprotein subclasses in hypercholesterolemia and combined hyperlipidemia.

  2007cited by this paper
• Preferential Sphingosine-1-Phosphate Enrichment and Sphingomyelin Depletion Are Key Features of Small Dense HDL3 Particles: Relevance to Antiapoptotic and Antioxidative Activities

  2007cited by this paper
• Endothelial lipase is less effective at influencing HDL metabolism in vivo in mice expressing apoA-II Published, JLR Papers in Press, July 30, 2006.

  2006cited by this paper
• Mechanisms of Disease: proatherogenic HDL—an evolving field

  2006cited by this paper
• High-Density Lipoproteins Enhance Progenitor-Mediated Endothelium Repair in Mice

  2006cited by this paper
• Reciprocal and Coordinate Regulation of Serum Amyloid A Versus Apolipoprotein A-I and Paraoxonase-1 by Inflammation in Murine Hepatocytes

  2006cited by this paper
• Endothelial and antithrombotic actions of HDL.

  2006cited by this paper
• Antioxidant and cytoprotective properties of high-density lipoproteins in vascular cells.

  2006cited by this paper
• Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels

  2006cited by this paper
• Relationship between total cholesterol/high-density lipoprotein cholesterol ratio, triglyceride/high-density lipoprotein cholesterol ratio, and high-density lipoprotein subclasses.

  2006cited by this paper
• Apolipoprotein CIII in Apolipoprotein B Lipoproteins Enhances the Adhesion of Human Monocytic Cells to Endothelial Cells

  2006cited by this paper
• Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel

  2006cited by this paper
• Alterations of high-density lipoprotein subclasses in endogenous hypertriglyceridemia.

  2005cited by this paper
• Effects of Cholesteryl Ester Transfer Protein Inhibition on High-Density Lipoprotein Subspecies, Apolipoprotein A-I Metabolism, and Fecal Sterol Excretion

  2005cited by this paper
• Rapid Communication Overexpression of Human Apolipoprotein A-II in Transgenic Mice Does Not Impair Macrophage-Specific Reverse Cholesterol Transport In Vivo

  2005cited by this paper
• Value of High-Density Lipoprotein (HDL) Subpopulations in Predicting Recurrent Cardiovascular Events in the Veterans Affairs HDL Intervention Trial

  2005cited by this paper
• Relationship between plasma lipid concentrations and HDL subclasses.

  2005cited by this paper
• Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux Published, JLR Papers in Press, August 1, 2005. DOI 10.1194/jlr.M500187-JLR200

  2005cited by this paper
• Human Apolipoprotein A-II Enrichment Displaces Paraoxonase From HDL and Impairs Its Antioxidant Properties: A New Mechanism Linking HDL Protein Composition and Antiatherogenic Potential

  2004cited by this paper
• Apolipoprotein gene cluster on chromosome 19

  2004cited by this paper
• Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

  2004cited by this paper
• The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk

  2004cited by this paper
• Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides.

  2004cited by this paper
• HDL in atherosclerosis: actor or bystander?

  2003cited by this paper
• Apolipoprotein A-II Inhibits High Density Lipoprotein Remodeling and Lipid-poor Apolipoprotein A-I Formation*

  2003cited by this paper
• Overexpression of Apolipoprotein A-I Promotes Reverse Transport of Cholesterol From Macrophages to Feces In Vivo

  2003cited by this paper
• The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease.

  2003cited by this paper
• Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment.

  2003cited by this paper
• Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.

  2003cited by this paper
• Effects on Lipoprotein Subclasses of Combined Expression of Human Hepatic Lipase and Human apoB in Transgenic Rabbits

  2003cited by this paper
• Impaired capacity of acute-phase high density lipoprotein particles to deliver cholesteryl ester to the human HUH-7 hepatoma cell line.

  2002cited by this paper
• High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.

  2001cited by this paper
• HDL and the inflammatory response induced by LDL-derived oxidized phospholipids.

  2001cited by this paper
• Studies on the plasma lipid profiles, and LCAT and CETP activities according to hyperlipoproteinemia phenotypes (HLP).

  2001cited by this paper
• Structural models of human apolipoprotein A-I: a critical analysis and review.

  2001cited by this paper
• Genetics and molecular biology.

  2001cited by this paper
• High-Density Lipoprotein Loses Its Anti-Inflammatory Properties During Acute Influenza A Infection

  2001cited by this paper
• In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions.

  2001cited by this paper
• Role of serum amyloid A during metabolism of acute-phase HDL by macrophages.

  2000cited by this paper
• Roles of Scavenger Receptor Bi and APO A-I in Selective Uptake of Hdl Cholesterol by Adrenal Cells

  2000cited by this paper
• Infection and inflammation-induced proatherogenic changes of lipoproteins.

  2000cited by this paper
• Resistant hypertriglyceridemia in a patient with high plasma levels of apolipoprotein CII.

  2000cited by this paper
• Apolipoprotein A-I: structure-function relationships.

  2000cited by this paper
• Specific Binding of ApoA-I, Enhanced Cholesterol Efflux, and Altered Plasma Membrane Morphology in Cells Expressing ABC1*

  2000cited by this paper
• Detailed molecular model of apolipoprotein A-I on the surface of high-density lipoproteins and its functional implications.

  2000cited by this paper
• A Detailed Molecular Belt Model for Apolipoprotein A-I in Discoidal High Density Lipoprotein*

  1999cited by this paper
• The ABCs of cholesterol efflux

  1999cited by this paper
• ApoA-II maintains HDL levels in part by inhibition of hepatic lipase. Studies In apoA-II and hepatic lipase double knockout mice.

  1999cited by this paper
• Interrelationships between postprandial lipoprotein B:CIII particle changes and high-density lipoprotein subpopulation profiles in mixed hyperlipoproteinemia.

  1999cited by this paper
• Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice.

  1999cited by this paper
• Decreased serum apolipoprotein AII/AI ratio in systemic amyloidosis

  1998cited by this paper
• Human apolipoprotein A-II is a pro-atherogenic molecule when it is expressed in transgenic mice at a level similar to that in humans: evidence of a potentially relevant species-specific interaction with diet.

  1998cited by this paper
• Understanding the mechanism of LCAT reaction may help to explain the high predictive value of LDL/HDL cholesterol ratio.

  1998cited by this paper
• 132 Protective effect of human apo A-II overexpression on atherogenesis in transgenic mice

  1997cited by this paper
• Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation.

  1997cited by this paper
• ApoA-II/apoA-I molar ratio in the HDL particle influences phospholipid transfer protein-mediated HDL interconversion.

  1997cited by this paper
• Efflux of Cellular Cholesterol and Phospholipid to Apolipoprotein A-I Mutants*

  1996cited by this paper
• Pre-beta HDL: structure and metabolism.

  1996cited by this paper
• Properties of an N-terminal proteolytic fragment of apolipoprotein AI in solution and in reconstituted high density lipoproteins

  1995cited by this paper
• Characterization of high-density apolipoprotein particles A-I and A-I:A-II isolated from humans with cholesteryl ester transfer protein deficiency.

  1995cited by this paper
• Apolipoprotein A-I Conformation in Reconstituted Discoidal Lipoproteins Varying in Phospholipid and Cholesterol Content (*)

  1995cited by this paper
• Phospholipid binding and lecithin-cholesterol acyltransferase activation properties of apolipoprotein A-I mutants.

  1995cited by this paper
• High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules.

  1995cited by this paper
• Molecular physiology of reverse cholesterol transport.

  1995cited by this paper
• Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice.

  1994cited by this paper
• A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells.

  1994cited by this paper
• Influence of apolipoprotein composition of high density lipoprotein particles on cholesteryl ester transfer protein activity. Particles containing various proportions of apolipoproteins AI and AII.

  1994cited by this paper
• International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. III. Comparability of apolipoprotein A-I values by use of international reference material.

  1993cited by this paper
• Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice.

  1993cited by this paper
• Abnormal activation of lipoprotein lipase by non-equilibrating apoC-II: further evidence for the presence of non-equilibrating pools of apolipoproteins C-II and C-III in plasma lipoproteins.

  1993cited by this paper
• Apolipoprotein A-I domains involved in lecithin-cholesterol acyltransferase activation. Structure:function relationships.

  1993cited by this paper
• Comparison of the plasma levels of apolipoproteins B and A-1, and other risk factors in men and women with premature coronary artery disease.

  1992cited by this paper
• Decreased HDL2 and HDL3 Cholesterol, Apo A‐I and Apo A‐II, and Increased Risk of Myocardial Infarction

  1992cited by this paper
• Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice.

  1992cited by this paper
• Site-directed mutagenesis and structure-function analysis of the human apolipoprotein A-I. Relation between lecithin-cholesterol acyltransferase activation and lipid binding.

  1992cited by this paper
• Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significance.

  1992cited by this paper
• Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I.

  1992cited by this paper
• Structure-Function Relationships

  1991cited by this paper
• Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses.

  1991cited by this paper
• Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease.

  1991cited by this paper
• Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit.

  1990cited by this paper
• Identifying the predominant peak diameter of high-density and low-density lipoproteins by electrophoresis.

  1990cited by this paper
• Defined apolipoprotein A-I conformations in reconstituted high density lipoprotein discs.

  1989cited by this paper
• High levels of human apolipoprotein A-I in transgenic mice result in increased plasma levels of small high density lipoprotein (HDL) particles comparable to human HDL3.

  1989cited by this paper
• Apolipoprotein C-III0 lacks carbohydrate residues: use of mass spectrometry to study apolipoprotein structure.

  1989cited by this paper

• Regulating the Size of Simvastatin-loaded Discoidal Reconstituted High-density Lipoprotein: Preparation, Characterization and Investigation of Cellular Cholesterol Efflux.

  2022cites this paper
• Assessment by Matrix‐Assisted Laser Desorption/Ionization Time‐of‐Flight Mass Spectrometry of the Effects of Preanalytical Variables on Serum Peptidome Profiles Following Long‐Term Sample Storage

  2018cites this paper
• Moderate dyslipoproteinemia induced inflammation and remodeling HDL and VLDL particles in post-renal transplant patients

  2017cites this paper
• Correlation between the High Density Lipoprotein and its Subtypes in Coronary Heart Disease

  2016cites this paper
• High Density Lipoprotein Protects Mesenchymal Stem Cells from Oxidative Stress-Induced Apoptosis via Activation of the PI3K/Akt Pathway and Suppression of Reactive Oxygen Species

  2012cites this paper
• A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease.

  2012cites this paper
• Current world literature.

  2012cites this paper
• Main Determinants of PON1 Activity in Hemodialysis Patients

  2012cites this paper